Migration-stimulating factor as a novel biomarker in salivary gland tumours

Journal of Oral Pathology and Medicine

Volumn 40, Issue 10, 2011, Pages 747-754

  Aljorani, Lateef E ^a   Bankfalvi, Agnes ^b   Carey, Frank A ^c   Harada, Koji ^a,d   Ohe, Go ^a,e   Jones, Sarah J ^a   Ellis, Ian R ^a   Schor, Seth L ^a   Schor, Ana M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Benign tumours; Cancer; Disease progression; MSF; Salivary gland tumours

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; MIGRATION STIMULATING FACTOR; PARAFFIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CARCINOMA CELL; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONSENSUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND TUMOR; STAINING; STROMA CELL; UPREGULATION;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054106037     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01044.x     Document Type: Article

References (21)

1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002; 8: 229-40.
2. WHO Classification of Tumours. Pathology and genetics of head and neck tumours. Lyon, France: IARC Press, 2005.
3. Cawson RA. Essentials of dental surgery and pathology, 3rd edn. Churchill Livingstone: Edinburgh, 1978.
4. Ward MJ, Levine PA. Salivary gland tumours. In: Close LG, Larson DL, Shah JP eds Essentials of head and neck oncology, 1st edn. New York, NY: Thieme, 1998.
5. Schor SL, Ellis IR, Jones SJ, et al. Migration stimulating factor (MSF): a genetically-truncated fibronectin isoform expressed by carcinoma and tumour-associated stromal cells. Cancer Res 2003; 63: 8827-36.
6. Kay RA, Ellis IR, Jones SJ, et al. The expression of MSF, a potent onco-fetal cytokine, is uniquely controlled by 3' UTR-dependent nuclear sequestration of its precursor mRNA. Cancer Res 2005; 65: 10742-9.
7. Schor SL, Schor AM, Keatch RP, Belch JJF. Role of matrix macromolecules in the aetiology and treatment of chronic ulcers. The Wound Healing Management Manual: Chapter 10, 2005; 109-21 (Bok Y Lee).
8. Hu H, Ran Y, Zhang Y, et al. Antibody library-base tumor endothelial cells surface proteomic functional screen reveals migration stimulating factor as an anti- angiogenic target. Mol Cell Proteomics 2009; 8: 816-26.
9. Schor AM, Schor SL. Angiogenesis and tumour progression. Migration-stimulating factor as a novel target for clinical intervention. Eye (Lond) 2010; 24: 450-8.
10. Houard X, Germain S, Gervais M, et al. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration. Int J Cancer 2005; 116: 378-84.
11. Schor AM, Pendleton N, Pazouki S, et al. Assessment of vascularity in histological sections: Effects of methodology and value as an index of angiogenesis in breast tumours. Histochem J 1998; 30: 849-56.
12. Baillie R, Harada K, Carlile J, Macluskey M, Schor SL, Schor AM. Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies. Histochem J 2001; 33: 287-94.
13. Shirasuna K, Sato M, Miyazaki T. A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer (Phila.) 1981; 48: 745-52.
14. Motegi K, Harada K, Ohe G, et al. Differential involvement of TGF-beta 1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells. Exp Cell Res 2008; 314: 2323-33.
15. Schor SL, Schor AM. The effect of fibronectin on the adhesion and migration of Chinese hamster ovary cells on collagen substrata. J Cell Sci 1980; 49: 299-310.
16. Schor AM, Schor SL. The isolation and culture of endothelial cells and pericytes from the bovine retinal microvasculature: a comparative study with large vessel vascular cells. Microvasc Res 1986; 32: 21-38.
17. Schor SL, Ellis I, Dolman C, et al. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J Cell Sci 1996; 109: 2581-90.
18. Schor SL, Ellis IR, Harada K, et al. A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay. Cell Motil Cytoskeleton 2006; 63: 287-300.
19. Yoshino I, Kometani T, Shoji F, et al. Induction of epithelial-mesenchymal transition-related genes by benzo(a)pyrene in lung cancer cells. Cancer 2007; 110: 369-74.
20. Schor AM, Rushton G, Ferguson JE, Howell A, Redford J, Schor SL. Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int J Cancer 1994; 59: 25-32.
21. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953; 6: 963-8.